Big Movers : NVIDIA (NASDAQ:NVDA), First Solar (NASDAQ:FSLR), EnLink Midstream Partners (NYSE:ENLK), Peoples Bancorp Inc. (NASDAQ:PEBO), Gerdau S.A. (NYSE:GGB)

A subsidiary of NVIDIA Corporation (NASDAQ:NVDA), Icera, has reportedly sought the intervention of the European antitrust organ while accusing QUALCOMM (QCOM) of anti-competitive practices. Icera is a British cellphone chip manufacturer. It claims that Qualcomm is using patent incentives and other pricing strategies to deny it business. NVIDIA Corporation (NASDAQ:NVDA) belongs to Technology sector. Its…

Read More

Eye Catching Stocks : Cypress Semiconductor (NASDAQ:CY), Broadcom (NASDAQ:BRCM), BluePhoenix Solutions (NASDAQ:BPHX), Investment Technology (NYSE:ITG), AirMedia Group Inc. (NASDAQ:AMCN)

Embedded nonvolatile memory specialist, Cypress Semiconductor, and Shanghai Huali Microelectronics Corporation (HLMC), one of the most advanced pure play wafer foundries in China, have announced the companies have developed functioning silicon cells using Cypress’s SONOS (Silicon Oxide Nitride Oxide Silicon) embedded Flash memory intellectual property (IP) at the 55-nanometer process technology node. Cypress Semiconductor Corporation…

Read More

Stock Runners : Brocade Communications Systems (NASDAQ:BRCD), Marathon Oil Corporation (NYSE:MRO), Echelon Corporation (NASDAQ:ELON), Infosys Ltd. (NYSE:INFY), The Babcock & Wilcox (NYSE:BWC)

Brocade Communications Systems, Inc. (NASDAQ:BRCD) has maintained an uptrend on its stock since it recently reported improved results in its 3Q. The stock is up more than 11% over the past one week and gained 0.29% to close at $10.35 in the last session. Analysts at Pacific Crest recently restated their “sector-perform” rating on the…

Read More

Hot Alert : ImmunoGen (NASDAQ:IMGN), Walt Disney Company (NYSE:DIS), Shanda Games Limited (NASDAQ:GAME), EQT Midstream Partners, LP (NYSE:EQM), Northeast Bancorp (NASDAQ:NBN)

The National Institute of Health and Care Excellence (NICE) – the drugs advisory body to the National Health Service (NHS) in the UK – has criticized Roche Holding Ltd. (ADR) (RHHBY) over its refusal to cut prices for Kadcyla, which is used to treat severe cases of breast cancer. Kadcyla is approved to treat HER2-positive…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓